Qiang Yao1, Weiming Zhang, Jiaqi Qian. 1. Shanghai Center for Hemodialysis Quality Control, Shanghai Municipal Bureau of Health, Shanghai, People's Republic of China.
Abstract
INTRODUCTION: As economic development continues in China, it is important to evaluate recent changes in dialysis status. However, China lacks a national dialysis registry. This elevates the need to use local registry systems like the Shanghai Dialysis Registry to gain an overview of dialysis status in developed cities in China. METHODS: Data were collected from the Shanghai Dialysis Registry from the beginning of 2000 to the end of 2005. All dialysis centers (n = 58) in Shanghai are included in the registry system. RESULTS: Point prevalence of dialysis on December 31, 2005, was 5496, compared with 4842 in 2000. In 2005, 3746 patients began dialysis, yielding a treatment rate of 275.4 patients per million population. The percentage of peritoneal dialysis patients was 18% in 2005, compared with 14% in 2000. The main cause for end-stage renal disease was chronic glomerulonephritis. However, the incidence of diabetic nephropathy increased from 9.9% in 2000 to 17.2% in 2005 and counts as the second major cause of end-stage renal disease. The death rate of patients on dialysis decreased from 9.2% in 2000 to 7.5% in 2005. Cerebrovascular disease was still the leading cause of death and decreased significantly from 2.4% in 2000 to 1.5% in 2005. Dialysis adequacy, hepatitis infection control, and anemia treatment improved. CONCLUSIONS: The Shanghai dialysis population grew continuously during the period covered by this study (2000 to 2005). Clinical outcomes improved because of prompt treatment for co-morbidities.
INTRODUCTION: As economic development continues in China, it is important to evaluate recent changes in dialysis status. However, China lacks a national dialysis registry. This elevates the need to use local registry systems like the Shanghai Dialysis Registry to gain an overview of dialysis status in developed cities in China. METHODS: Data were collected from the Shanghai Dialysis Registry from the beginning of 2000 to the end of 2005. All dialysis centers (n = 58) in Shanghai are included in the registry system. RESULTS: Point prevalence of dialysis on December 31, 2005, was 5496, compared with 4842 in 2000. In 2005, 3746 patients began dialysis, yielding a treatment rate of 275.4 patients per million population. The percentage of peritoneal dialysis patients was 18% in 2005, compared with 14% in 2000. The main cause for end-stage renal disease was chronic glomerulonephritis. However, the incidence of diabetic nephropathy increased from 9.9% in 2000 to 17.2% in 2005 and counts as the second major cause of end-stage renal disease. The death rate of patients on dialysis decreased from 9.2% in 2000 to 7.5% in 2005. Cerebrovascular disease was still the leading cause of death and decreased significantly from 2.4% in 2000 to 1.5% in 2005. Dialysis adequacy, hepatitis infection control, and anemia treatment improved. CONCLUSIONS: The Shanghai dialysis population grew continuously during the period covered by this study (2000 to 2005). Clinical outcomes improved because of prompt treatment for co-morbidities.
Authors: Xiao Lu Jiang; Ji Qiu Wen; Long Jiang Zhang; Gang Zheng; Xue Li; Zhe Zhang; Ya Liu; Li Juan Zheng; Long Wu; Hui Juan Chen; Xiang Kong; Song Luo; Guang Ming Lu; Xue Man Ji; Zong Jun Zhang Journal: Metab Brain Dis Date: 2016-05-11 Impact factor: 3.584
Authors: Brian Bieber; Jiaqi Qian; Shuchi Anand; Yucheng Yan; Nan Chen; Mia Wang; Mei Wang; Li Zuo; Fan Fan Hou; Ronald L Pisoni; Bruce M Robinson; Sylvia P B Ramirez Journal: Nephrol Dial Transplant Date: 2013-12-08 Impact factor: 5.992
Authors: Pietro A Modesti; Piergiuseppe Agostoni; Charles Agyemang; Sanjay Basu; Athanase Benetos; Francesco P Cappuccio; Antonio Ceriello; Stefano Del Prato; Robert Kalyesubula; Eoin O'Brien; Michael O Kilama; Stefano Perlini; Eugenio Picano; Gianpaolo Reboldi; Giuseppe Remuzzi; David Stuckler; Marc Twagirumukiza; Luc M Van Bortel; Ghassan Watfa; Dong Zhao; Gianfranco Parati Journal: J Hypertens Date: 2014-05 Impact factor: 4.844